Efficacy and tolerance of dupilumab in patients with moderate-to-severe atopic dermatitis and obesity

被引：1

作者：

Dupuis, Josephine ^{[1
]}

Tauber, Marie ^{[2
,3
]}

Mahe, Emmanuel ^{[4
]}

Jachiet, Marie ^{[5
]}

Soria, Angele ^{[6
]}

Tetart, Florence ^{[7
]}

Puzenat, Eve ^{[8
]}

Pasteur, Justine ^{[9
]}

Raison-Peyron, Nadia ^{[10
]}

Giordano-Labadie, Francoise ^{[11
]}

Droitcourt, Catherine ^{[12
]}

Leleu, Camille ^{[13
]}

Nosbaum, Audrey ^{[3
]}

Aubert, Helene ^{[14
]}

Moigne, Marie L. E. ^{[14
]}

Bernier, Claire ^{[14
]}

Barbarot, Sebastien ^{[15
]}

Ezzedine, Khaled ^{[16
]}

Diaz, Emmanuelle ^{[16
]}

Hubiche, Thomas ^{[17
]}

Faiz, Sarah ^{[18
]}

Azib, Selma ^{[1
]}

Dezoteux, Frederic ^{[1
,19
]}

Chosidow, Olivier ^{[20
]}

Staumont-Salle, Delphine ^{[1
,19
]}

机构：

[1] CHU Lille, Serv Dermatol, F-59037 Lille, France

[2] CHU Toulouse, Hop Larrey, Serv Dermatol, Toulouse, France

[3] Hop Lyon Sud, Allergol & Immunol Clin, CIRI Inserm U1111, Lyon, France

[4] Hop Victor Dupouy, Serv Dermatol, Argenteuil, France

[5] Hop St Louis, Dermatol, AP HP, Paris, France

[6] Hop Tenon, AP HP, Dermatol & Allergol, Paris, France

[7] CHU Rouen, Dermatol, Rouen, France

[8] CHU Besancon, Dermatol, Besancon, France

[9] CHU Clermont Ferrand, Dermatol, Clermont Ferrand, France

[10] CHU Montpellier, Dermatol, Montpellier, France

[11] CHU Toulouse, Dermatol, Toulouse, France

[12] Univ Rennes, Irset Inst Rech Sante, Dept Dermatol, CHU Rennes,Inserm,EHESP,UMR S 1085, Rennes, France

[13] Hop Bocage, Dermatol, Dijon, France

[14] CHU Nantes, Dermatol, Nantes, France

[15] Nantes Univ, Dept Dermatol, CHU Nantes, INRAE,UMR 1280,PhAN, Nantes, France

[16] Hop Henri Mondor, AP HP, Dermatol, Creteil, France

[17] Hop Archet 2, Dermatol, Nice, France

[18] CH Douai, Dermatol, Douai, France

[19] Univ Lille, Lille Inflammat Translat Res Inst INFINITE, INSERM U1286, Lille, France

[20] Univ Hosp La Pitie Salpetriere, AP HP, Facial Dermatosis Clin, Paris, France

来源：

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY | 2025年 / 39卷 / 02期

关键词：

D O I：

10.1111/jdv.20264

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

引用

页码：e174 / e178

页数：5

共 50 条

[41] Use of Dupilumab in 543 Adult Patients With Moderate-to-Severe Atopic Dermatitis: A Multicenter, Retrospective Study
Nettis, E.
Ferrucci, S. M.
Ortoncelli, M.
Pellacani, G.
Foti, C.
Di Leo, E.
Patruno, C.
Rongioletti, F.
Argenziano, G.
Macchia, L.
Tavecchio, S.
Napolitano, M.
Ribero, S.
Bonzano, L.
Romita, P.
Di Bona, D.
Nistico, S. P.
Piras, V
Calabrese, G.
Detoraki, C.
Carbonara, M.
Fabbrocini, G.
JOURNAL OF INVESTIGATIONAL ALLERGOLOGY AND CLINICAL IMMUNOLOGY, 2022, 32 (02) : 124 - 132
[42] Depth and rapidity of response with abrocitinib and dupilumab in patients with moderate-to-severe atopic dermatitis in JADE COMPARE
Lio, P.
Boguniewicz, M.
Alexis, A.
Lebwohl, M.
Reich, K.
Pink, A.
Kabashima, K.
Bissonnette, R.
Nowicki, R. J.
Valdez, H.
Zhang, F.
DiBonaventura, M.
Clibborn, C.
Cameron, M. C.
BRITISH JOURNAL OF DERMATOLOGY, 2021, 185 (03) : E138 - E139
[43] Tear fluid dupilumab levels of patients with moderate-to-severe atopic dermatitis and ocular surface disease
Achten, R.
Thijs, J.
van Luijk, C.
van Wijk, F.
van Luin, M.
El Amrani, M.
Delemarre, E.
de Graaf, M.
Bakker, D.
de Boer, J.
de Bruin-Weller, M.
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2022, 142 (12) : S196 - S196
[44] Sexual dysfunction in a cohort of patients with moderate-to-severe atopic dermatitis. Influence of dupilumab treatment
Linares-Gonzalez, Laura
Lozano-Lozano, Ignacio
Gutierrez-Rojas, Luis
Ruiz-Villaverde, Ricardo
Lozano-Lozano, Mario
INTERNATIONAL JOURNAL OF DERMATOLOGY, 2022, 61 (05) : 607 - 610
[45] Real-life effectiveness and safety of dupilumab in adult patients with moderate-to-severe atopic dermatitis
Salman, Andac
Sengun, Ozlem Apti
Aktas, Meryem
Taskapan, Oktay
DERMATOLOGIC THERAPY, 2022, 35 (01)
[46] Efficacy and safety of dupilumab in Japanese adults with moderate-to-severe atopic dermatitis: a subanalysis of three clinical trials
Katoh, N.
Kataoka, Y.
Saeki, H.
Hide, M.
Kabashima, K.
Etoh, T.
Igarashi, A.
Imafuku, S.
Kawashima, M.
Ohtsuki, M.
Fujita, H.
Arima, K.
Takagi, H.
Chen, Z.
Shumel, B.
Ardeleanu, M.
BRITISH JOURNAL OF DERMATOLOGY, 2020, 183 (01) : 39 - 51
[47] Efficacy and Safety of Upadacitinib vs Dupilumab in Adults With Moderate-to-Severe Atopic Dermatitis A Randomized Clinical Trial
Blauvelt, Andrew
Teixeira, Henrique D.
Simpson, Eric L.
Costanzo, Antonio
De Bruin-Weller, Marjolein
Barbarot, Sebastien
Prajapati, Vimal H.
Lio, Peter
Hu, Xiaofei
Wu, Tianshuang
Liu, John
Ladizinski, Barry
Chu, Alvina D.
Eyerich, Kilian
JAMA DERMATOLOGY, 2021, 157 (09) : 1047 - 1055
[48] COVID-19 Symptoms Are Attenuated in Moderate-to-Severe Atopic Dermatitis Patients Treated with Dupilumab
Ungar, Benjamin
Glickman, Jacob W.
Golant, Alexandra K.
Dubin, Celina
Marushchak, Olga
Gontzes, Alyssa
Mikhaylov, Daniela
Singer, Giselle K.
Baum, Danielle
Wei, Nancy
Sanin, Antonio
Gruenstein, Diana
Lebwohl, Mark G.
Pavel, Ana B.
Guttman-Yassky, Emma
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2022, 10 (01): : 134 - 142
[49] Dupilumab treatment induces rapid clinical improvement of itch in patients with moderate-to-severe atopic dermatitis
Silverberg, Jonathan I.
Eckert, Laurent
Ardeleanu, Marius
Chen, Zhen
Akinlade, Bolanle
Plaum, Stefan
Graham, Neil M. H.
Pirozi, Gianluca
Gadkari, Abhijit
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2018, 79 (03) : AB113 - AB113
[50] Ophthalmological characteristics and treatment outcomes of conjunctivitis in patients receiving dupilumab for moderate-to-severe atopic dermatitis
Lans, A.
Van Luijk, C. M.
Bakker, D. S.
Ariens, L. F. M.
Thijs, J. L.
Van der Schaft, J.
De Boer, J. H.
Knol, E. F.
De Bruin-Weller, M. S.
Balak, D. M. W.
ALLERGY, 2019, 74 : 714 - 714

← 1 2 3 4 5 →